MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.dld.2024.12.011

Медицинская библиотека · Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2025

Change in fatigue in patients with ulcerative colitis or Crohn's disease initiating biologic therapy.

Louis Edouard, Bossuyt Peter, Colard Arnaud, Nakad Antoine, Baert Didier, Mana Fazia, Caenepeel Philip, Branden Stijn Vanden, Vermeire Severine, D'Heygere Francois, Strubbe Beatrijs, Cremer Anneline, Setakhr Vida, Baert Filip, Vijverman Anne, Coenegrachts Jean-Louis, Flamme Frederic, Hantson Anke, Zhou Jie, Van Gassen Geert

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Fatigue is common among patients with inflammatory bowel diseases (IBDs) and is associated with decreased quality of life (QoL).

AIMS: Describe fatigue evolution and identify factors associated with fatigue outcomes in patients with ulcerative colitis (UC) or Crohn's disease (CD) initiating biologic treatment.

METHODS

Data from adult Belgian patients with UC or CD enrolled in a prospective real-world study were utilized. Fatigue and QoL were assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) and the Short Inflammatory Bowel Disease Questionnaire, respectively. Factors associated with fatigue outcomes were assessed using multivariate regression.

RESULTS

465 patients were included: 174 with UC and 291 with CD. Average FACIT-F scores indicated improvements in fatigue after 6 months, before stabilizing. A higher probability of fatigue disappearance was associated with clinical remission and was more likely in patients with UC than CD. Patients achieving clinical remission had lower probability of fatigue. Patients with fatigue improvements experienced greater QoL improvements than patients with fatigue persistence.

CONCLUSIONS

Real-world findings suggest fatigue partly improves in the first 6 months of biologic treatment. Clinical remission was associated with greater probability of fatigue disappearance and lower likelihood of fatigue persistence. Further research into factors associated with fatigue in patients with IBD is warranted.

Для цитирования: Louis Edouard, Bossuyt Peter, Colard Arnaud, Nakad Antoine, Baert Didier, Mana Fazia, Caenepeel Philip, Branden Stijn Vanden, Vermeire Severine, D'Heygere Francois, Strubbe Beatrijs, Cremer Anneline, Setakhr Vida, Baert Filip, Vijverman Anne, Coenegrachts Jean-Louis, Flamme Frederic, Hantson Anke, Zhou Jie, Van Gassen Geert. Change in fatigue in patients with ulcerative colitis or Crohn's disease initiating biologic therapy.. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2025. DOI: 10.1016/j.dld.2024.12.011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.